Trial Search Results

Showing 1 - 4 of 4 trials – Showing only trials currently accepting patients

• Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

  Stanford is currently accepting patients for this trial.

• Testing The Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia

  Stanford is currently accepting patients for this trial.

• Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia

  Stanford is currently accepting patients for this trial.

• Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children

  Stanford is currently accepting patients for this trial.